Plestina Stjepko

Katarina Cular, Kristina Kanceljak, Ana Magdalena Glas, Dora Gudelj, Marija Krizic,Marina Popovic, Natalija Dedic Plavetic, Maja Sirotkovic-Skerlev,Stjepko Plestina,Tajana Silovski

CANCER RESEARCHno. 9 (2024)

引用0浏览0引用

Impact of the Number of Therapy Lines on Survival in Advanced Gastric and Esophagogastric Adenocarcinoma - a Real-World Retrospective Analysis from Croatia

Vesna Bisof,Andrija Katic,Majana Soce,Marina Vidovic,Jelena Viculin,Stjepko Plestina,Eduard Vrdoljak

NEOPLASMAno. 2 (2024): 201-208

引用0浏览0WOS引用

A Response To: Artificial Immortalization, Number of Therapy Lines, and Survival of Patients with Advanced Gastric and Esophagogastric Adenocarcinoma

Vesna Bišof,Andrija Katić,Majana Soče,Marina Vidović,Jelena Viculin,Stjepko Pleština,Eduard Vrdoljak

Neoplasmano. 4 (2024): 415-416

引用0浏览0WOS引用

74P Real-world Progression-Free and Overall Survival of Patients with Metastatic Colorectal Cancer According to First and Second-Line Treatment Regimen: PROMETCO Study

M. Koopman, R. Garcia-Carbonero, C. Pinto, A. Mitroshkin, G. Bodoky, Marti, J. M. R. O'Connor, S. John, J. I. Sgouros, H. F. Mansinho, R. Greil,P-J. Cuyle,S. Plestina,J. Ocvirk, A. Sullivan, E. Choucair, B. Chevallier,J-B. Bachet

ANNALS OF ONCOLOGY (2024): S36-S36

引用0浏览0引用

Differences in Outcomes Between Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer Patients in Upper Middle-Income versus High-Income Countries: A Retrospective Study from 4 Oncology Centers